Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection

      Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection

      Medical Dialogues Bureau1 Aug 2019 9:25 AM IST
      "The United States Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredient manufacturing facility located at...
      Dr Reddys net profit up by 45 percent to Rs 663 crore for June quarter

      Dr Reddys net profit up by 45 percent to Rs 663 crore for June quarter

      Medical Dialogues Bureau1 Aug 2019 9:15 AM IST
      "This quarter, we grew in most of our key markets and hope to continue this momentum with a sharper focus on performance," Dr Reddy's Laboratories...
      Bayer, Orion prostate cancer drug Daroluramide wins USFDA nod

      Bayer, Orion prostate cancer drug Daroluramide wins USFDA nod

      Medical Dialogues Bureau1 Aug 2019 9:00 AM IST
      According to the 2014 deal, Bayer has the right to commercialise daroluramide globally while Orion will manufacture the product and receive milestone...
      Pfizer generic unit Upjohn to merge with Mylan; new entity aims revenue of 19-20 billion Dollar for 2020

      Pfizer generic unit Upjohn to merge with Mylan; new entity aims revenue of 19-20 billion Dollar for 2020

      Medical Dialogues Bureau31 July 2019 10:18 PM IST
      New Delhi: Mylan N.V. and Pfizer Inc have announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic...
      Dr Reddys anticipates USFDA inspection of Srikakulam plant by year-end

      Dr Reddy's anticipates USFDA inspection of Srikakulam plant by year-end

      Medical Dialogues Bureau31 July 2019 9:46 AM IST
      The USFDA had issued a warning letter in November 2015 relating to Current Good Manufacturing Practice (CGMP) deviations at Dr Reddy's API...
      Shilpa Medicare gets 5 USFDA observations for Raichur facility

      Shilpa Medicare gets 5 USFDA observations for Raichur facility

      Medical Dialogues Bureau31 July 2019 9:30 AM IST
      "We have received Form 483 with five observations, with no repeat observations and any data integrity observations. The observations are mostly...
      Dr Reddys unveils generic version of Lyrica capsules in US for treating neuropathic pain

      Dr Reddy's unveils generic version of Lyrica capsules in US for treating neuropathic pain

      Medical Dialogues Bureau31 July 2019 9:16 AM IST
      Dr Reddy's Labs' Pregabalin capsule is a generic version of C P Pharmaceuticals International C V's Lyrica capsules which had US sales of around...
      Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore

      Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore

      Medical Dialogues Bureau31 July 2019 9:00 AM IST
      Piramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
      NeuroVives NeuroSTAT Project Receives USFDA Fast Track Designation

      NeuroVive's NeuroSTAT Project Receives USFDA Fast Track Designation

      Medical Dialogues Bureau30 July 2019 2:20 PM IST
      NeuroVive Pharmaceutical AB announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain...
      Cipla Gulf, Alvotech partner to commercialise AVT02 Biosimilar of AbbVies Blockbuster drug Humira

      Cipla Gulf, Alvotech partner to commercialise AVT02 Biosimilar of AbbVie's Blockbuster drug Humira

      Medical Dialogues Bureau30 July 2019 1:15 PM IST
      Mumbai: Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical...
      Strides Pharma inks JV pact with Chinas Sihuan Pharma

      Strides Pharma inks JV pact with China's Sihuan Pharma

      Medical Dialogues Bureau30 July 2019 12:47 PM IST
      China: Strides Pharma Science said on Monday it has entered into a joint venture with China's Sihuan Pharmaceutical Holdings Group with a view to fast...
      Cipla asks Government to increase fund allocation for healthcare sector

      Cipla asks Government to increase fund allocation for healthcare sector

      Medical Dialogues Bureau29 July 2019 6:09 PM IST
      Addressing shareholders in the company's Annual Report for 2018-19, Cipla Chairman Y K Hamied said basic healthcare in the country will always require...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok